EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    What Changes at Scale, and How Do You Know?

    A pharmaceutical process that performs reliably on a few grams of material can behave very differently at pilot or commercial scale The temperature setpoint that worked on the bench the mixing time that delivered a uniform blend the feed rate that kept a reaction on track none of these is guaranteed to mean the same thing in larger equipment When that difference goes...

KNOWLEDGE BANK

  • Articles

    Revolutionizing Health: The Future of Gene Editing and Genetic Engineering

    In the realm of healthcare few advancements hold as much promise and controversy as gene editing and genetic engineering These technologies once confined to science fiction are now tangible tools

    Pharmaceutical Serialization in Europe: Ensuring Safety in the Supply Chain

    Over the past few years however Europes pharmaceutical companies have faced a rather challenging role of fighting counterfeiting of medicines and therefore their patients Serialization it is a system that uses a special code assigned to every product has become one of the salient solutions to tackle counterfeit drugs While serialization in terms

    The Impact of AI and Machine Learning on Drug Discovery

    Now and then an industry hits a point where the old ways no matter how trusted start to feel a bit like trying to run a marathon in hiking boots Drug discovery is in that spot For decades pharmaceutical RD leaned heavily on long painstaking experiments and the occasional stroke of luck Entire teams would spend years nudging molecules around waiting for a hint that something might work After all th...

    Manufacturing mRNA, Cell, and Gene Therapies at Commercial Scale

    Why Cell and Gene Therapies Fail in Europe After the Science Has Already Worked The uncomfortable statistic for anyone financing advanced therapies in Europe is not the clinical attrition rate It is the withdrawal rate after approval An analysis of advanced therapy medicinal products granted European marketing authorisation found that roughly one in five had subsequently been withdrawn and of th...

    Implementing Quality by Design (QbD) in Pharmaceutical Development: Enhancing Product Quality and Regulatory Compliance

    Quality by Design QbD stands as a systematic strategy for pharmaceutical development prioritizing predefined product objectives and emphasizing a thorough understanding of both the product and its manufacturing processes This proactive approach integrates quality seamlessly into the development process championing a sciencedriven

    Navigating the Pharma Market: Strategies for Successful Pharmaceutical Sales

    Navigating the pharmaceutical market requires a blend of strategic planning industry knowledge and effective communication skills In this guide well explore key strategies for successful pharmaceutical sales in a way thats easy to understand

TOP ARTICLES

  • 2

    The Impact of AI and Machine Learning on Drug Discovery

    Satyajit Shinde

    Artificial intelligence (AI) and machine learning (ML) are revolutionising drug discovery by dramatically accelerating the identification and development of new therapies. These technologies analyse v...

press releases Read more...

Sino Biological Introduces AI-Trusted and Qualified Target Protein Collections for AI-Driven Discovery

As AI accelerates recombinant protein and antibody discovery for therapeutic and diagnostic development access to wellcharacterized target proteins is essential for evaluating AIdesigned molecules Sino Biological Inc Shenzhen Stock Exchange SZ a global biotechnology company

Sanofi’s next-generation rabies vaccine, VaxRabeo, approved in the EU for all ages

Sanofi announced today that the European Commission has approved VaxRabeo rabies virus inactivated strain Wistar for preexposure prophylaxis PrEP and postexposure prophylaxis PEP against rabies for all age groups

Datapharm appoints healthcare leaders to help shape the future of trusted medicines information

Datapharm the company behind emc the UKs trusted source of regulatorapproved medicines information today announced the formation of its Strategic Advisory Board bringing together senior figures from across pharma medical affairs and patient advocacy

Erasca Enters into Clinical Collaboration with Bristol Myers Squibb to Evaluate ERAS-0015 in Clinical Study with Navlimetostat

Erasca Inc Nasdaq ERAS a clinicalstage precision oncology company singularly focused on discovering developing and commercializing therapies for patients with RASMAPK pathwaydriven cancers today announced a clinical

24 - 27

Nov 2026

Pharmtech & Ingredients 2026

Crocus Expo, Pavilion 2, Mosco...

24 - 25

Nov 2026

BioPharma Deals Conference 2026

Science Congress Center, Munic...

25 - 25

Nov 2026

What’s Next for Pharma Marketing in 2027

Landesmuseum Zürich, Zurich, S...

26 - 28

Nov 2026

One Health Conference 2026

Thapar Institute of Engineerin...

01 - 03

Dec 2026

Pharmaceutical Launch Excellence Summit

Novotel Amsterdam City, Nether...

01 - 03

Dec 2026

10th Antifibrotic Drug Development

Boston, MA at the Hotel Common...

02 - 04

Dec 2026

Genome Informatics 2026

Wellcome Genome Campus, UK

03 - 04

Dec 2026

LATEST NEWS Read more...

DISCO Pharmaceuticals Partners with AbbVie to Develop Next-Generation Bispecific Therapies for Solid Tumours

DISCO Pharmaceuticals has entered into a strategic collaboration and optiontolicense agreement with AbbVie to discover and develop nextgeneration ANDgated bispecific therapies for solid tumours with significant unmet medical needs

CAI Enters Agreement with PQE Group to Expand Global Life Sciences Services

CAI a professional services firm specialising in operational readiness and excellence for life sciences and other critical industries has entered into a definitive agreement with PQE Group a global consulting firm focused on quality compliance

Erasca Partners with Bristol Myers Squibb to Study ERAS-0015 Combination Therapy for Pancreatic Cancer

Erasca Inc a clinicalstage precision oncology company focused on developing treatments for cancers driven by the RASMAPK signalling pathway has entered into a clinical trial collaboration and supply agreement with Bristol Myers Squibb BMS

Libtayo Receives EU Approval for Extended Dosing and Shorter Infusion Times Across Six Cancer Indications

Regeneron Pharmaceuticals has received European Commission EC approval for an alternative dosing schedule for Libtayo cemiplimab across all six of its approved indications for skin lung and cervical cancers in the European Union EU

FDA approves Roche’s Wilserdly for ER-positive, ESR1-mutated advanced breast cancer

Roche has received approval from the US Food and Drug Administration FDA for Wilserdly giredestrant in combination with everolimus to treat adults with oestrogen receptor ERpositive human epidermal growth factor receptor HERnegative ESRmutated locally advanced or metastatic breast cancer

European Commission approves Revolution Medicines’ RASONQUE for metastatic pancreatic cancer

Revolution Medicines has received European Commission EC approval for RASONQUE daraxonrasib to treat adults with metastatic pancreatic adenocarcinoma who have received at least one previous systemic therapy The medicine is taken once daily as an oral tablet and is approved for patients with or witho...